生命科学资讯
生物技术与制药领域的最新动态
组学实验室服务：2021-2025年全球市场回顾与2026-2031年预测，重点介绍安捷伦科技、Q2 Solutions、Flomics Biotech、QIAGEN、赛默飞世尔科技等公司概况 - 雅虎财经
Omics Lab Services: Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Profiles of Agilent Technologies, Q2 Solutions, Flomics Biotech, QIAGEN, Thermo Fisher Scientific and More - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Purchases 40,166 Shares of Illumina, Inc. $ILMN - MarketBeat
乐天投资管理公司购入安捷伦科技公司新股份 $A - MarketBeat
Rakuten Investment Management Inc. Purchases New Shares in Agilent Technologies, Inc. $A - MarketBeat
$4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leading Players - Yahoo Finance Singapore
Cantillon资本管理公司减持赛默飞世尔科技股份
Cantillon Capital Management LLC Lowers Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
10x Genomics将于2026年2月12日公布2025年第四季度及全年财务业绩 - Finviz
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Finviz
10x Genomics临床野心扩张，势头超越分析师预期 - simplywall.st
10x Genomics Expands Clinical Ambitions As Momentum Outruns Analyst Targets - simplywall.st
Robust assessment of asymmetric division in colon cancer cells
Computational modelling identifies key determinants of subregion-specific dopamine dynamics in the striatum
龙沙集团（场外交易代码：LZAGY）交易量激增——现在是买入时机吗？- MarketBeat
Lonza Group (OTCMKTS:LZAGY) Sees Large Volume Increase - Time to Buy? - MarketBeat
10x Genomics将于2026年2月12日公布2025年第四季度及全年财务业绩 - Stock Titan
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Stock Titan
10x Genomics将于2026年2月12日公布2025年第四季度及全年财务业绩 - 雅虎财经
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Yahoo Finance
行业圆桌：小分子原料药：2026年展望——DCAT价值链洞见
Industry Roundtable: Small-Molecule APIs: What’s in Store for 2026? - DCAT Value Chain Insights
Illumina股价上涨5.9%：CMS支持TruSight Oncology全面报销方案
Why Illumina (ILMN) Is Up 5.9% After CMS Backs TruSight Oncology Comprehensive Reimbursement - simplywall.st
美国国立卫生研究院全面禁止在研究中使用流产胎儿组织。
NIH imposes full ban of aborted fetal tissue in research
最高法院在让问题“酝酿”后，选择了希克玛的“瘦身标签”之争。
High court picked Hikma’s ‘skinny label’ fight after letting the issue ‘percolate’
投资者为“差异化”减肥药向Corxel注资2.87亿美元
Investors load Corxel with $287M for a ‘differentiated’ obesity pill
制药公司在2025年最后一季度减少了华盛顿游说支出
Drugmakers spent less on Washington lobbying in 2025's final quarter
Janux的肿瘤激活平台吸引BMS达成潜在8.5亿美元交易
Janux’s tumor-activated platform draws BMS in potential $850M deal